We observed different levels of CD45 staining in primary versus recurrent tumor patients, with 2 versus 0 patients showing no (−), 3 versus 0 patients showing low (+), 3 versus 4 medium (++), and 11 versus 16 high (+++) staining. Here, PTPRC is linked to neoplasm.